Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ventracor's VentrAssist:

This article was originally published in Clinica

Executive Summary

Ventracor has CE-marked the new version of its VentrAssist left ventricular assist device (LVAD), allowing the product's sale in Europe. The new device, called LVA4, uses the VentrAssist blood pump with a thinner percutaneous lead, which, it is hoped, will lower the risk of infection. It also has a replaceable external extension wire to the controller, allowing replacements of the external part of the wire if it becomes damaged, or worn after long-term use. The LVA4 has a more flexible outflow cannula for greater surgical flexibility, the Melbourne, Australia firm said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel